Next Previous

Our Pledge

At the World Economic Forum in 2017, CEOs from more than 20 leading biopharmaceutical companies came together to launch Access Accelerated, pledging:

Kitale, Kenya

We envision a future where no one dies prematurely from a treatable, preventable disease and all people living with or at risk of non-communicable diseases (NCDs) have access to appropriate, quality, and affordable prevention, treatments and care.

 

To that end, we commit to helping achieve the United Nations Sustainable Development Goals, and in particular, the target to reduce premature deaths from NCDs by one-third by 2030. NCDs, including cancer, cardiovascular diseases, chronic respiratory diseases, diabetes and mental health disorders are the leading causes of death and disability worldwide. Unless action is taken to reverse the trend, this burden is expected to rise significantly in developing countries in the coming decades.

 

Responding to the call of world leaders for the private sector to apply creativity and innovation to solve sustainable development challenges in the Sustainable Development Goals, we understand that the private sector, including the innovative health care and pharmaceutical industry has an important role to play in achieving the NCD goal. We can help improve the prevention, care and treatment of NCDs through our medicines and vaccines. With resources and capabilities we stand ready to work together toward our goal.

 

But, we cannot do this alone. Working together with partners like The World Bank Group, the Union for International Cancer Control (UICC), civil society, other international organizations and governments we can make measurable and sustainable progress against this rising incidence of NCDs particularly for aging populations in developing countries.

 

To achieve this, together and individually, we make the following commitments:

  •  Targeted pilots to address barriers. With a view to a broader scale-up, we will undertake pilot programs to test ways to improve the treatment of NCDs and strengthen health systems in low and lower-middle income countries. We will partner with the World Bank Group to accelerate access to care, medicines and technologies through sustainable and scalable solutions, with an initial focus on several country pilots supporting primary enablers of quality NCD care, including early screening, diagnosis and basic treatment. The World Bank Group will enhance these pilot programs at a country-level through their ongoing work with the government on financing, regulatory and other barriers to access.

 

  •  Expanded collaboration and partnerships. We will find new ways to address gaps in access, share best practices and advance solutions. As peers – and as competitors – this will not always be easy, but we believe our industry can work as one for the benefit of addressing these diseases. This will mean collaborating systematically and thinking beyond any one organization’s capabilities and initiatives.

 

  •  Seeking strength outside of ourselves. We will partner broadly to understand the full range of access barriers, adding value to current efforts and/or creating new initiatives where needed. We will listen carefully to develop effective partnerships that address access and availability in each of the major NCD areas, building on the individual strengths and capabilities of our partners.

 

  •  Disease specific partnerships. Our initial disease focus will be on cancer. We will join the Union for International Cancer Control (UICC)’s C/Can 2025: City Cancer Challenge as a foundational partner to support the development of effective, sustainable cancer care delivery models in select lower income cities. Through this partnership, we will work with other stakeholders to develop solutions at the local level to address disparities in access to cancer medicines and care. Other disease specific partnerships are possible in the future.

 

  •  Rigorous measurement and full transparency. We will work with independent experts at Boston University, the World Bank Group, UICC, and others to evaluate and share what works, what does not and what real-world impact our efforts have on NCDs with ongoing reporting.

 

Access Accelerated will be guided by what people need, delivered by aligned individual efforts and accelerated by broad dynamic partnerships. Together, we can help people, no matter where they live, to enjoy longer, healthier lives.

 

Member Companies

Almirall, Astellas, Bayer, Bristol-Myers Squibb, Chiesi, Chugai, Daiichi-Sankyo, Eisai, Lilly, Ipsen, Johnson & Johnson, Menarini, Merck KGaA, MSD, Novartis, Pfizer, Roche, Sanofi, Servier, Shionogi, Sumitomo Dainipon, Takeda and UCB.

 

Trade Associations

Biotechnology Innovation Organization (BIO); European Federation of Pharmaceutical Industries and Associations (EFPIA); International Federation of Pharmaceutical Manufacturers & Associations (IFPMA); Japan Pharmaceutical Manufacturers Association(JPMA); and Pharmaceutical Research and Manufacturers of America (PhRMA).

Contact

Have a question? Fill out the form below to get in touch.

Terms of Use

IFPMA (“we”, “us”) owns and operates www.ifpma.org (“the/our website”). Any person accessing and/or using the website (“the visitor/user”) agrees to the “Terms of Use”, containing the conditions, rules and other provisions with respect to the access and/or use of our website. If you have questions about the “Terms of Use”, please feel free to contact us at admin@ifpma.org.

CONTENT

General Use

The material contained on this website is for information only. The website is entitled to be served as an information resource for the internal and external stakeholders of IFPMA, including the general public. Third-Party Websites Links to other websites are provided solely as a convenience and therefore imply neither IFPMA’s responsibility for, nor its approval of the information contained in these websites. Intellectual Property Any use of information from the website should have an acknowledgement of IFPMA/Third-Party as a source respectively, citing the corresponding uniform resource locator (URL). Logo and Name The use of IFPMA’s name and/or logo is prohibited without prior express authorization from IFPMA. The access and/or use of the website does not permit to copy, reproduce, modify, distribute or elsehow exploit IFPMA’s name and/or logo except with the prior explicit permission. Abuse and Violation Any abuse or violations of the Terms of Use and/or Privacy Policy should be reported to admin@ifpma.org.

DISCLAIMER

IFPMA renounces any liability or responsibility for any damages of any nature whatsoever resulting from the use of, inability to use, and/or reliance on the material and information contained on our website. IFPMA makes no representations or warranties as to the completeness or accuracy of any of the information available on the website as well as does not provide any warranties regarding the security of the content of our website or any linked websites. IFPMA endeavours to make its best effort to keep the information accurate and updated on a regular basis, however this is not claimed to be exhaustive. IFPMA does not guarantee that the website is continuously available and error-free at all times.

Privacy Policy

IFPMA is committed to protecting the privacy and security of visitors to our website. Outlined below is our online privacy policy for information collected through our website. If you have questions about these policies, please feel free to contact us at admin@ifpma.org.

Personal Information

We constantly analyse our website logs to improve the value of our website. We do not use this analysis to record or track any personally identifiable information of our visitors. If you are asked to provide personal information such as your name, e-mail or/and postal address when requesting information, providing feedback, registering to a newsletter, or using any other functions of the website, be assured that all such information is considered by IFPMA both private and secure. IFPMA does not share or sell your personal information to third parties. Under no circumstance will details be disclosed publicly, except in order to comply with any legal obligation. This policy reiterates that IFPMA fully appreciates the importance of online privacy and is committed to protecting your personal information.

Use of Cookies Files

Our website is enhanced by cookie files to personalize and customize the experience of our visitors and to support some necessary functions. IFPMA collects broad usage statistics using Google Analytics, to better understand how our visitors use our website, and to help us improve visitors’ experience. Such information includes the IP address (where available), browser type, and any additional information provided by a browser during the use of our website. The statistical data about our users’ browsing actions and patterns does not identify any individual. You may choose to accept or refuse cookies by modifying your browser preferences. If you wish to get notified when a cookies are set, this option should also be available in your browser settings. Please note that if you reject some or all cookies, your experience at this and other websites throughout the Internet may not be complete.

Payment Transactions

To enable IFPMA to process any order or registration to an event, a secure online payment system may be used to process payments using credit card details. IFPMA will not be collecting or storing credit card details in our system.

Third-Party Websites

Please be aware that other websites to which links may be provided, including social media, may collect visitor’s personally identifiable information when accessed. The information collection practices of other websites linked to IFPMA’s website are not covered by this Privacy Policy.

Cookie Policy

Some of our web pages utilise “cookies”. A “cookie” is a small text file that may be used, for example, to collect information about web site activity. Some cookies and other technologies may serve to recall Personal Information previously indicated by a web user. Most browsers allow you to control cookies, including whether or not to accept them and how to remove them.

Some cookies are necessary for the operation of our website, if you choose to block them some aspects of the site may not work for you. Non necessary cookies are only set when you have given your explicit consent to their use. Such cookies included those set by our statistics package Google Analytics.

We are committed to privacy and support current industry initiatives to preserve individual privacy rights on the Internet. Protecting your privacy on-line is an evolving area and this website will constantly evolve to meet these demands.